One of these suggested stocks features a dividend yield topping 10%.
Pfizer's stock has started to turn higher, but it is still down massively; is now the time to jump aboard?
Pfizer's Q3 earnings fell, but the company still raised its full-year earnings guidance. Major cost reductions remain on track, which should significantly boost the drugmaker's bottom line. Pfizer's ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results